The global Jet Lag Therapy Market will be worth USD 548.5 million by 2027, according to a current analysis by Emergen Research. Jet lag symptoms cause a wide variety of considerable health hazards to athletes, business executives and seasonal travelers, affecting a wide range of people which is around 1 billion annually. Over the years, it has been found that jet lag has very distinctive effects on the lives of travelers or those affected with this condition. There has a wide range of advancements throughout the development of recent trend setting technologies that possess properties that prevent symptoms with less effects, as compared to traditional product such as prescription drugs and melatonin.

The latest research report by Emergen Research, named ‘Global Jet Lag Therapy Market - Forecast to 2027’, entails a comprehensive review of the global Jet Lag Therapy market’s present and future trends. The report gathers viable information on the most established industry players, sales and distribution channels, regional spectrum, estimated market share and size, and revenue estimations over the forecast timeframe.

Get a Free Sample Copy, visit @https://www.emergenresearch.com/request-sample/190

COVID-19 Impact Analysis:

This report is the latest document encompassing the massive changes that took place in the Jet Lag Therapy market following the emergence of the COVID-19 pandemic. The pandemic has drastically affected the global economic landscape, thereby disrupting the operating mechanism of the Jet Lag Therapy market. The severe global crisis has prompted organizations to efficiently respond to the rapidly shifting business environment. Therefore, the report fully covers the profound impact of COVID-19 on this industry, with a special focus on the affected industry segments.

Key Highlights From The Report.

  • In July 2019, Vanda Pharmaceuticals received the FDA approval as a part of its ongoing review of Vanda's supplemental New Drug Application (sNDA) for HETLIOZ® (tasimelteon). The drug was developed in order to treat Jet Lag Disorder especially for eastward trans-meridian travelers.
  • The medical devices segment, especially the wearable devices has been gaining traction over the years and is likely to grow at a CAGR of 3.9% over the forecast period. This can be attributed to the fact that wearable devices are versatile in nature (in terms of relevance and portability) and are majorly preferred by athletes. attributable to their advancements inside the essential style, thereby, giving a good vary of choices for numerous end-user teams.

Competitive Outlook:

  • The global Jet Lag Therapy market is highly consolidated due to the presence of a large number of companies across this industry. These companies are known to make hefty investments in research and development projects. Also, they control a considerable portion of the overall market share, thus limiting the entry of new players into the sector. The global Jet Lag Therapy market report studies the prudent tactics undertaken by the leading market players, such as partnerships and collaborations, mergers & acquisitions, new product launches, and joint ventures.

Some of the key participants in this industry include:

  • Nature Bright
  • Lumie
  • Northern Light Technologies
  • Re-Timer
  • Propeaq
  • Royal Philips
  • Lucimed
  • Valkee
  • Vielight Inc.

Key questions addressed in the report:

  • What are the key factors driving the global Jet Lag Therapy market?
  • Who are the key manufacturers in this market space?
  • Who are the distributors, traders and dealers of this market?
  • What are the market opportunities and risks affecting the performance of the vendors in the global Jet Lag Therapy market?

Read More @https://www.emergenresearch.com/industry-report/jet-lag-therapy-market

About Us:

At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.

Contact Us:

Emergen Research | Web: www.emergenresearch.com

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Browse More Related Reports: